kabutan

Kidswell Bio, Operating Loss Forecast for the Fiscal Year Revised Upward to 0.30-0.60 Billion Yen

Thu Nov 13, 2025 4:00 pm JST Earnings

4584 Kidswell Bio Corporation 【J-GAAP】

Earnings Report

Kidswell Bio Corporation <4584> [TSE Growth] announced its financial results after the market closed on November 13th (16:00). The consolidated operating profit/loss for the cumulative second quarter of the fiscal year ending March 2026 (April to September) turned into a profit of 0.21 billion yen (compared to a loss of 0.26 billion yen in the same period last year).

In addition, the full-year forecast for consolidated operating loss has been revised upward from the previous range of 1.00 billion to 1.70 billion yen to a new range of 0.30 billion to 0.60 billion yen.

In the most recent three-month period, from July to September (2Q), the consolidated operating profit/loss turned to a profit of 0.03 billion yen (compared to a loss of 0.10 billion yen in the same period last year). The operating profit/loss margin drastically improved from -8.2% in the same period last year to 2.0%.

Note: If the earnings forecast is disclosed as a range, the article is based on the midpoint of that range.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Sep, 2023 581 -719 -744 -780 -24.1 ー Nov 8, 2023 J-GAAP
Apr - Sep, 2024 1,749 -262 -267 -241 -6.1 ー Nov 12, 2024 J-GAAP
Apr - Sep, 2025 3,276 215 76 60 1.3 ー Nov 13, 2025 J-GAAP
YoY +87.3% － － － －

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2025 Guidance ー ー ー ー － 0 May 13, 2025 J-GAAP
Apr - Sep, 2025 Results 3,276 215 76 60 1.3 0 Nov 13, 2025 J-GAAP
Revision Rate － － － － －

Guidance Update

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2026 Prev 5,250 -1,350 ー ー － 0 May 13, 2025 J-GAAP
Mar, 2026 New 5,750 -450 ー ー － 0 Nov 13, 2025 J-GAAP
Revision Rate +9.5% +66.7% － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 3,333 289 272 220 5.5 0 May 13, 2025 J-GAAP
Oct - Mar, 2025 Guidance 2,474 -665 ー ー － 0 Nov 13, 2025 J-GAAP
YoY -25.8% － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 2,431 -1,335 -1,389 -1,422 -40.2 0 May 14, 2024 J-GAAP
Mar, 2025 5,082 27 5 -21 -0.5 0 May 13, 2025 J-GAAP
Mar, 2026 Guidance 5,750 -450 ー ー － 0 Nov 13, 2025 J-GAAP
YoY +13.1% － － － －

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2024 1,267 -104 -91 -65 -1.6 -8.2 Nov 12, 2024 J-GAAP
Oct - Dec, 2024 1,287 125 106 54 1.4 9.7 Feb 12, 2025 J-GAAP
Jan - Mar, 2025 2,046 164 166 166 4.1 8.0 May 13, 2025 J-GAAP
Apr - Jun, 2025 1,720 184 175 157 3.3 10.7 Aug 13, 2025 J-GAAP
Jul - Sep, 2025 1,556 31 -99 -97 -2.0 2.0 Nov 13, 2025 J-GAAP
YoY +22.8% － -8.8% -49.2% -24.4%

Related Articles